Editorial: Over the holiday period, the Guardian leader column is looking ahead at the themes of 2026. Today we examine how the White House's war on vaccines has left the future of a key technology uncertain and up for grabs ...
'Really? The project is years behind schedule and billions of dollars over budget. That's the result of erratic support from the Trump administration?,' writes an L.A. Times reader.